Position in HLN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$764,742
+$735,443 QoQ
Shares Held
81,966
+2700.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#158
of 639 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 33%
Shared 0%
None 67%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $14,581,452 across 56 Drug Manufacturers - Specialty & Generic names. HLN ranks #4 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
24,261 | $4,088,948 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
6,216 | $3,368,015 | |
| 3 | VTRS |
Viatris Inc
|
83,877 | $1,331,966 | |
| 4 | HLN |
Haleon plc
This page
|
81,966 | $764,742 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
21,768 | $737,499 | |
| 6 | ZTS |
Zoetis Inc.
|
9,047 | $650,117 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
39,210 | $628,536 | |
| 8 | IRWD |
Ironwood Pharmaceuticals Inc
|
126,966 | $534,526 |
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $764,742 | 81,966 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $29,299 | 2,927 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $87,876 | 8,692 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $83,438 | 9,302 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $45,482 | 4,386 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $45,471 | 4,419 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $48,196 | 5,052 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $56,137 | 5,306 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $44,703 | 5,412 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $47,807 | 5,631 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $44,919 | 5,458 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $8,171 | 981 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,220 | 981 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,977 | 980 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $7,840 | 980 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $5,968 | 980 | Shares | Sole | 2022-11-03 | |
| No filing history on record for this holder in this stock. | ||||||